Author:
Gao Rong,Cheng Jianhua,Fan Chunlei,Shi Xiaofeng,Cao Yuan,Sun Bo,Ding Huiguo,Hu Chengjin,Dong Fangting,Yan Xianzhong
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Lanaya, H. et al. EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat. Cell Biol. 16, 972–981 (2014).
2. Dhanasekaran, R., Limaye, A. & Cabrera, R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Hepat. Med. 4, 19–37 (2012).
3. Flores, A. & Marrero, J. A. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics. Clin. Med. Insights Oncol. 8, 71–76 (2014).
4. Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030–3044 (2006).
5. Farrell, G. C. et al. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J. Gastroenterol. Hepatol. 25, 657–663 (2010).
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献